PIK3R2 and neuroblastoma: Decreased mRNA-expression of PIK3R1 has previously been detected in aggressive neuroblastoma [9], although no significant difference in p85 protein levels were seen comparing stage 1–2 and stage 4 tumors (Figure 2B) along with only a modest decrease in MYCN amplified tumors (Additional file 1).